Lista de obras -

A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis

scientific article published on 17 January 2020

A comparison between two strategies for monitoring hepatic function during antituberculous therapy

artículo científico publicado en 2011

A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor

scientific article published on 26 March 2020

A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis

artículo científico publicado en 2019

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.

artículo científico publicado en 2017

Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent

artículo científico publicado en 2020

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort

scientific article published on 12 July 2019

Bronchoalveolar Lavage is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study

artículo científico publicado en 2020

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.

artículo científico publicado en 2017

Cough Severity Visual Analogue Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary Fibrosis

artículo científico publicado en 2024

Could quality be the key in connective tissue disease-associated interstitial lung disease?

artículo científico publicado en 2018

Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.

scientific article published on 18 April 2016

Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease

scientific article published on 08 January 2020

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial

scientific article published on 28 August 2018

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

artículo científico publicado en 2023

Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy

artículo científico publicado en 2013

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.

artículo científico publicado en 2017

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

scientific article published on 01 March 2020

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

scientific journal article

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia

artículo científico publicado en 2016

Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.

artículo científico publicado en 2017

Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis

artículo científico publicado en 2021

In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality

scientific article published on 23 May 2019

Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype?

artículo científico publicado en 2020

Itaconate controls the severity of pulmonary fibrosis

artículo científico publicado en 2020

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

artículo científico publicado en 2015

Lung microbiology and exacerbations in COPD

artículo científico publicado en 2012

MUC5AC drives COPD exacerbation severity through amplification of virus-induced airway inflammation

artículo científico publicado en 2019

Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design

scientific article published on 29 September 2019

Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial

artículo científico publicado en 2024

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

artículo científico publicado en 2013

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study

scientific article published on 02 October 2020

Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

artículo científico publicado en 2013

P19 GeneXpert MTB.Rif assay improves the diagnostic yield of EBUS-TBNA in smear-negative intra-thoracic tuberculous lymphadenopathy

article

PD-1 up-regulation on CD4 T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production

artículo científico publicado en 2018

Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound

artículo científico publicado en 2014

Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease

artículo científico publicado en 2020

Post-bronchoscopy sputum: improving the diagnostic yield in smear negative pulmonary TB.

artículo científico publicado en 2011

Presence of pleomorphic features but not growth patterns improves prognostic stratification of epithelioid malignant pleural mesothelioma by 2-tier nuclear grade

artículo científico publicado en 2020

Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

artículo científico publicado en 2020

Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations

artículo científico publicado en 2020

Rapidly Progressive Cystic Lung Disease

artículo científico publicado en 2018

Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK

artículo científico publicado en 2024

Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib

artículo científico publicado en 2013

Regularized Latent Class Model for Joint Analysis of High-Dimensional Longitudinal Biomarkers and a Time-to-Event Outcome

artículo científico publicado en 2018

Reply to Fujimoto <i>et al.</i>: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice

artículo científico publicado en 2022

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis

artículo científico publicado en 2019

Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study

artículo científico publicado en 2023

Respiratory microbiome and epithelial interactions shape immunity in the lungs

scientific article published on 20 March 2020

Respiratory microbiome in IPF: cause, effect, or biomarker?

artículo científico publicado en 2014

Review of the British Thoracic Society Winter Meeting 2017, 6-8 December 2017, London, UK

scientific article published on 14 June 2018

Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung Disease

artículo científico publicado en 2019

Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.

artículo científico publicado en 2017

Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression

artículo científico publicado en 2020

Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis

artículo científico publicado en 2020

The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis

scientific article published on 10 November 2019

The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis

scientific article published on 01 July 2019

The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study

artículo científico publicado en 2023

The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.

artículo científico publicado en 2017

The potential impact of azithromycin in idiopathic pulmonary fibrosis

scientific article published on 14 February 2019

The role of infection in the pathogenesis of idiopathic pulmonary fibrosis.

artículo científico publicado en 2013

Time for an International Consensus on Hypersensitivity Pneumonitis. A Call to Arms.

artículo científico publicado en 2017

Utility of Nuclear Grading System in Epithelioid Malignant Pleural Mesothelioma in Biopsy-heavy Setting: An External Validation Study of 563 Cases

artículo científico publicado en 2020

Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study

artículo científico publicado en 2011

Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.

artículo científico publicado en 2017

Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis

scientific article published on 25 July 2019

Lista de obras de

A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis

A comparison between two strategies for monitoring hepatic function during antituberculous therapy

A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor

A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.

Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort

Bronchoalveolar Lavage is Safe and Well Tolerated in Individuals with Idiopathic Pulmonary Fibrosis: An Analysis of the PROFILE Study

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.

Cough Severity Visual Analogue Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary Fibrosis

Could quality be the key in connective tissue disease-associated interstitial lung disease?

Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.

Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia

Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.

Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis

In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality

Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype?

Itaconate controls the severity of pulmonary fibrosis

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

Lung microbiology and exacerbations in COPD

MUC5AC drives COPD exacerbation severity through amplification of virus-induced airway inflammation

Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design

Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study

Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

P19 GeneXpert MTB.Rif assay improves the diagnostic yield of EBUS-TBNA in smear-negative intra-thoracic tuberculous lymphadenopathy

PD-1 up-regulation on CD4 T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production

Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound

Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease

Post-bronchoscopy sputum: improving the diagnostic yield in smear negative pulmonary TB.

Presence of pleomorphic features but not growth patterns improves prognostic stratification of epithelioid malignant pleural mesothelioma by 2-tier nuclear grade

Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations

Rapidly Progressive Cystic Lung Disease

Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK

Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib

Regularized Latent Class Model for Joint Analysis of High-Dimensional Longitudinal Biomarkers and a Time-to-Event Outcome

Reply to Fujimoto <i>et al.</i>: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis

Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study

Respiratory microbiome and epithelial interactions shape immunity in the lungs

Respiratory microbiome in IPF: cause, effect, or biomarker?

Review of the British Thoracic Society Winter Meeting 2017, 6-8 December 2017, London, UK

Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung Disease

Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.

Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression

Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis

The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis

The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis

The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study

The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.

The potential impact of azithromycin in idiopathic pulmonary fibrosis

The role of infection in the pathogenesis of idiopathic pulmonary fibrosis.

Time for an International Consensus on Hypersensitivity Pneumonitis. A Call to Arms.

Utility of Nuclear Grading System in Epithelioid Malignant Pleural Mesothelioma in Biopsy-heavy Setting: An External Validation Study of 563 Cases

Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study

Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.

Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis